Company intelligence / Profile preview

Shandong Sinobioway Biomedicine Co., Ltd.

Jinan, Shandong, Chinasinobioway.com ↗
Ownership
Private
Employees
~1300
Development stage
Other
01

Overview

The company has multiple approved products including Mouse nerve growth factor and Recombinant human interferon alpha-2b, with several other products in clinical development phases (Phase 1 and Phase 2).

Therapeutic areas
OncologyOphthalmologyNeurology
Modalities
Monoclonal antibodiesRecombinant proteinsGrowth factorsBiological productsPeptides
Industry
Biotech
02

Drug pipeline

1 asset

huwentoxin-IV

Unknown
03

Partnerships

Over 50 active collaborations with global research institutions

Beyond the preview

Go deeper on Shandong Sinobioway Biomedicine Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Sinobioway Biomedicine Co., Ltd..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call